PI
Pennant Investors Portfolio holdings
AUM $334M
1-Year Return
56.91%
This Quarter Return
+17.04%
1 Year Return
+56.91%
3 Year Return
+148.85%
5 Year Return
+226.03%
10 Year Return
–
AUM
$362M
AUM Growth
+$36.3M
(+11%)
Cap. Flow
-$11.8M
Cap. Flow
% of AUM
-3.26%
Top 10 Holdings %
Top 10 Hldgs %
95.42%
Holding
45
New
2
Increased
1
Reduced
3
Closed
1
Top Buys
| 1 |
Enovis
ENOV
|
+$25M |
| 2 |
Antero Resources
AR
|
+$6.38M |
Top Sells
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$26.6M |
| 2 |
Amazon
AMZN
|
+$9.38M |
| 3 |
Microsoft
MSFT
|
+$7.15M |
| 4 |
Travere Therapeutics
TVTX
|
+$502K |
Sector Composition
| 1 | Technology | 23.03% |
| 2 | Consumer Discretionary | 20.63% |
| 3 | Communication Services | 16.79% |
| 4 | Industrials | 14.41% |
| 5 | Healthcare | 11.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Amazon
AMZN
$2.5T
| $53.4M | 13.23% |
296,000
-52,000
| -15% | -$9.38M |
|
2
TransDigm Group
TDG
$72.6B
| $51.7M | 12.81% |
42,000
| – | – |
|
|
3
Microsoft
MSFT
$3.82T
| $47.1M | 11.67% |
112,000
-17,000
| -13% | -$7.15M |
|
4
Micron Technology
MU
$177B
| $36.1M | 8.94% |
306,000
| – | – |
|
|
5
Antero Resources
AR
$9.97B
| $32.9M | 8.14% |
1,133,000
+220,000
| +24% | +$6.38M |
|
6
EchoStar
SATS
$19.9B
| $30.7M | 7.6% |
2,153,209
| – | – |
|
|
7
Alphabet (Google) Class A
GOOGL
$3.05T
| $30M | 7.44% |
199,000
-176,000
| -47% | -$26.6M |
|
|
8
Enovis
ENOV
$1.86B
| $25M | 6.19% |
+400,000
| New | +$25M |
|
9
ODP
ODP
$633M
| $21.2M | 5.26% |
400,000
| – | – |
|
10
Perimeter Solutions
PRM
$3.13B
| $17.1M | 4.23% |
2,300,000
| – | – |
|
11
FibroGen
FGEN
$46.9M
| $1.81M | 0.45% |
30,736
| – | – |
|
12
Arcutis Biotherapeutics
ARQT
$2.03B
| $1.69M | 0.42% |
170,900
| – | – |
|
13
Altimmune
ALT
$324M
| $1.12M | 0.28% |
109,800
| – | – |
|
14
Fate Therapeutics
FATE
$112M
| $1.07M | 0.27% |
146,100
| – | – |
|
15
Nurix Therapeutics
NRIX
$652M
| $835K | 0.21% |
56,800
| – | – |
|
16
MacroGenics
MGNX
$98M
| $645K | 0.16% |
43,800
| – | – |
|
|
IGMS
17
DELISTED
IGM Biosciences
IGMS
| $626K | 0.16% |
64,900
| – | – |
|
18
Enanta Pharmaceuticals
ENTA
$163M
| $613K | 0.15% |
35,100
| – | – |
|
19
Allogene Therapeutics
ALLO
$266M
| $574K | 0.14% |
128,400
| – | – |
|
20
89bio
ETNB
$1.2B
| $518K | 0.13% |
44,500
| – | – |
|
21
Zentalis Pharmaceuticals
ZNTL
$102M
| $511K | 0.13% |
32,400
| – | – |
|
22
Arcus Biosciences
RCUS
$1.26B
| $447K | 0.11% |
23,700
| – | – |
|
23
Arcturus Therapeutics
ARCT
$508M
| $442K | 0.11% |
13,100
| – | – |
|
24
Agios Pharmaceuticals
AGIO
$2.16B
| $442K | 0.11% |
15,100
| – | – |
|
|
GETR
25
DELISTED
Getaround, Inc.
GETR
| $414K | 0.1% |
1,348,153
| – | – |
|